Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients

References

• Wang Q, Zhang Y, Wu L, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020 May 14;181(4):894–904.e9. DOI:https://doi.org/10.1016/j.cell.2020.03.045. PubMed PMID: 32275855; PubMed Central PMCID: PMCPMC7144619.
   PubMed Web of Science ®Google Scholar
• Walls AC, Park Y-J, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292.e6. DOI:https://doi.org/10.1016/j.cell.2020.02.058.
   PubMed Web of Science ®Google Scholar
• Ju B, Zhang Q, Ge J, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020 May 26;584(7819):115–119. DOI:https://doi.org/10.1038/s41586-020-2380-z. PubMed PMID: 32454513.
   PubMed Web of Science ®Google Scholar
• Cao Y, Su B, Guo X, et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell. 2020 Jul 9;182(1):73–84 e16. DOI:https://doi.org/10.1016/j.cell.2020.05.025. PubMed PMID: 32425270; PubMed Central PMCID: PMCPMC 7231725.
   PubMed Web of Science ®Google Scholar
• Kreer C, Zehner M, Weber T, et al. Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients. Cell. 2020 Jul 13;182(4):843–854.e12. DOI:https://doi.org/10.1016/j.cell.2020.06.044. PubMed PMID: 32673567; PubMed Central PMCID: PMCPMC7355337.
   PubMed Web of Science ®Google Scholar
• Barnes CO, West AP Jr, Huey-Tubman KE, et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell. 2020 Jun 24;182(4):828–842.e16. DOI:https://doi.org/10.1016/j.cell.2020.06.025. PubMed PMID: 32645326; PubMed Central PMCID: PMCPMC7311918.
   PubMed Web of Science ®Google Scholar
• Wec AZ, Wrapp D, Herbert AS, et al. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science. 2020;369(6504):731–736.
   PubMed Web of Science ®Google Scholar
• Robbiani DF, Gaebler C, Muecksch F, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 Jun 18;584(7821):437–442. DOI:https://doi.org/10.1038/s41586-020-2456-9. PubMed PMID: 32555388.
   PubMed Web of Science ®Google Scholar
• Shi R, Shan C, Duan X, et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 May 26;584(7819):120–124. DOI:https://doi.org/10.1038/s41586-020-2381-y. PubMed PMID: 32454512.
   PubMed Web of Science ®Google Scholar
• Rogers TF, Zhao F, Huang D, et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020;369(6506):956–963.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang F, Shen C, et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020;368:1274–1278.
   PubMed Web of Science ®Google Scholar
• Seydoux E, Homad LJ, MacCamy AJ, et al. Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation. Immunity. 2020;53:1–8. DOI:https://doi.org/10.1016/j.immuni.2020.06.001.
   Google Scholar
• Liu L, Wang P, Nair MS, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584(7821):450–456. DOI:https://doi.org/10.1038/s41586-020-2571-7.
   PubMed Web of Science ®Google Scholar
• Zost SJ, Gilchuk P, Chen RE, et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nature Medicine. 2020;26(9):1422–1427. DOI:https://doi.org/10.1038/s41591-020-0998-x.
   PubMed Web of Science ®Google Scholar
• Brouwer PJM, Caniels TG, Straten K, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369(6504):643–650.
   PubMed Web of Science ®Google Scholar
• Yuan M, Liu H, Wu NC, et al. Structural basis of a shared antibody response to SARS-CoV-2. Science. 2020;369(6507):1119–1123.
   PubMed Web of Science ®Google Scholar
• Hurlburt NK, Seydoux E, Wan YH, et al. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat Commun. 2020 Oct 27;11(1):5413. DOI:https://doi.org/10.1038/s41467-020-19231-9. PubMed PMID: 33110068; PubMed Central PMCID: PMCPMC7591918.
   PubMed Web of Science ®Google Scholar
• Piccoli L, Park YJ, Tortorici MA, et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell. 2020 Sep 16;183(4):1024–1042.e21. DOI:https://doi.org/10.1016/j.cell.2020.09.037. PubMed PMID: 32991844; PubMed Central PMCID: PMCPMC 7494283.
   PubMed Web of Science ®Google Scholar
• Niu X, Yan Q, Yao Z, et al. Longitudinal analysis of the antibody repertoire of a Zika virus-infected patient revealed dynamic changes in antibody response. Emerg Microbes Infect. 2020;9(1):111–123. DOI:https://doi.org/10.1080/22221751.2019.1701953. PubMed PMID: 31906823; PubMed Central PMCID: PMCPMC6968589.
   PubMed Web of Science ®Google Scholar
• Davis CW, Jackson KJL, McElroy AK, et al. Longitudinal analysis of the human B cell response to Ebola Virus infection. Cell. 2019 May 30;177(6):1566–1582 e17. doi: https://doi.org/10.1016/j.cell.2019.04.036. PubMed PMID: 31104840; PubMed Central PMCID: PMCPMC6908968.
   PubMed Web of Science ®Google Scholar
• Setliff I, McDonnell WJ, Raju N, et al. Multi-donor longitudinal antibody repertoire sequencing reveals the existence of public antibody clonotypes in HIV-1 infection. Cell Host Microbe. 2018 Jun 13;23(6):845–854 e6. DOI:https://doi.org/10.1016/j.chom.2018.05.001. PubMed PMID: 29861170; PubMed Central PMCID: PMCPMC6002606.
   PubMed Web of Science ®Google Scholar
• Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol. 2020 Jul 23;38(9):1073–1078. DOI:https://doi.org/10.1038/s41587-020-0631-z. PubMed PMID: 32704169.
   PubMed Web of Science ®Google Scholar
• Feng L, Wang Q, Shan C, et al. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Nat Commun. 2020 Aug 21;11(1):4207. DOI:https://doi.org/10.1038/s41467-020-18077-5. PubMed PMID: 32826924.
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014 Aug 1;30(15):2114–2120. DOI:https://doi.org/10.1093/bioinformatics/btu170. PubMed PMID: 24695404; PubMed Central PMCID: PMCPMC 4103590.
   PubMed Web of Science ®Google Scholar
• Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011 Nov 1;27(21):2957–2963. DOI:https://doi.org/10.1093/bioinformatics/btr507. PubMed PMID: 21903629; PubMed Central PMCID: PMCPMC 3198573.
   PubMed Web of Science ®Google Scholar
• Bolotin DA, Poslavsky S, Mitrophanov I, et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods. 2015 May;12(5):380–381. DOI:https://doi.org/10.1038/nmeth.3364. PubMed PMID: 25924071.
   PubMed Web of Science ®Google Scholar
• Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32(5):1792–1797. DOI:https://doi.org/10.1093/nar/gkh340. PubMed PMID: 15034147; PubMed Central PMCID: PMCPMC390337.
   PubMed Web of Science ®Google Scholar
• Kumar S, Stecher G, Li M, et al. MEGA x: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018 Jun 1;35(6):1547–1549. DOI:https://doi.org/10.1093/molbev/msy096. PubMed PMID: 29722887; PubMed Central PMCID: PMCPMC 5967553.
   PubMed Web of Science ®Google Scholar
• Yu G, Smith DK, Zhu H, et al. Ggtree : an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol. 2016;8(1):28–36. DOI:https://doi.org/10.1111/2041-210x.12628.
   Google Scholar
• Schwede T, Kopp J, Guex N, et al. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003 Jul 1;31(13):3381–3385. DOI:https://doi.org/10.1093/nar/gkg520. PubMed PMID: 12824332; PubMed Central PMCID: PMCPMC168927.
   PubMed Web of Science ®Google Scholar
• Chen L, Li L, Weng ZP. ZDOCK: an initial-stage protein-docking algorithm. Proteins. 2003;52:80-87.
   PubMed Web of Science ®Google Scholar
• Sun B, Feng Y, Mo X, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):940–948. DOI:https://doi.org/10.1080/22221751.2020.1762515. PubMed PMID: 32357808; PubMed Central PMCID: PMC PMC7273175.
   PubMed Web of Science ®Google Scholar
• Yuan M, Wu NC, Zhu X. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368:630-633.
   PubMed Web of Science ®Google Scholar
• Parameswaran P, Liu Y, Roskin KM, et al. Convergent antibody signatures in human dengue. Cell Host Microbe. 2013 Jun 12;13(6):691–700. DOI:https://doi.org/10.1016/j.chom.2013.05.008. PubMed PMID: 23768493; PubMed Central PMCID: PMCPMC4136508.
   PubMed Web of Science ®Google Scholar
• Jackson KJ, Liu Y, Roskin KM, et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe. 2014 Jul 9;16(1):105–114. DOI:https://doi.org/10.1016/j.chom.2014.05.013. PubMed PMID: 24981332; PubMed Central PMCID: PMCPMC4158033.
   PubMed Web of Science ®Google Scholar
• Soto C, Bombardi RG, Branchizio A, et al. High frequency of shared clonotypes in human B cell receptor repertoires. Nature. 2019 Feb;566(7744):398–402. DOI:https://doi.org/10.1038/s41586-019-0934-8. PubMed PMID: 30760926; PubMed Central PMCID: PMCPMC 6949180.
   PubMed Web of Science ®Google Scholar
• Briney B, Inderbitzin A, Joyce C, et al. Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature. 2019 Feb;566(7744):393–397. DOI:https://doi.org/10.1038/s41586-019-0879-y. PubMed PMID: 30664748; PubMed Central PMCID: PMCPMC6411386.
   PubMed Web of Science ®Google Scholar
• Cohen-Dvashi H, Zehner M, Ehrhardt S, et al. Structural basis for a convergent immune response against Ebola Virus. Cell Host Microbe. 2020 Mar 11;27(3):418–427 e4. doi:https://doi.org/10.1016/j.chom.2020.01.007. PubMed PMID: 32059794.
   Google Scholar
• Ehrhardt SA, Zehner M, Krahling V, et al. Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nat Med. 2019 Oct;25(10):1589–1600. DOI:https://doi.org/10.1038/s41591-019-0602-4. PubMed PMID: 31591605.
   PubMed Web of Science ®Google Scholar
• Robbiani DF, Bozzacco L, Keeffe JR, et al. Recurrent potent human neutralizing antibodies to Zika Virus in Brazil and Mexico. Cell. 2017 May 4;169(4):597–609 e11. DOI:https://doi.org/10.1016/j.cell.2017.04.024. PubMed PMID: 28475892; PubMed Central PMCID: PMCPMC5492969.
   PubMed Web of Science ®Google Scholar
• Chen F, Tzarum N, Wilson IA, et al. VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design. Curr Opin Virol. 2019 Feb;34:149–159. DOI: https://doi.org/10.1016/j.coviro.2019.02.004. PubMed PMID: 30884330; PubMed Central PMCID: PMCPMC7266006.
   PubMed Web of Science ®Google Scholar
• Wu NC, Andrews SF, Raab JE, et al. Convergent evolution in breadth of two VH6-1-encoded influenza antibody clonotypes from a single donor. Cell Host Microbe. 2020;28:1–11. DOI:https://doi.org/10.1016/j.chom.2020.06.003.
   Google Scholar
• Wu X. HIV broadly neutralizing antibodies: VRC01 and beyond. Adv Exp Med Biol. 2018;1075:53–72. DOI:https://doi.org/10.1007/978-981-13-0484-2_3. PubMed PMID: 30030789.
   Google Scholar
• Sok D, Burton DR. Recent progress in broadly neutralizing antibodies to HIV. Nat Immunol. 2018 Nov;19(11):1179–1188. DOI:https://doi.org/10.1038/s41590-018-0235-7. PubMed PMID: 30333615; PubMed Central PMCID: PMCPMC6440471.
   PubMed Web of Science ®Google Scholar
• Pappas L, Foglierini M, Piccoli L, et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature. 2014 Dec 18;516(7531):418–422. DOI:https://doi.org/10.1038/nature13764. PubMed PMID: 25296253.
   PubMed Web of Science ®Google Scholar
• Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 Mar;591(7851):639–644. DOI:https://doi.org/10.1038/s41586-021-03207-w. PubMed PMID: 33461210.
   PubMed Web of Science ®Google Scholar
• Niu X, Zhao L, Qu L, et al. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model. Emerg Microbes Infect. 2019;8(1):749–759. DOI:https://doi.org/10.1080/22221751.2019.1614885. PubMed PMID: 31130109; PubMed Central PMCID: PMCPMC6542155.
   PubMed Web of Science ®Google Scholar
• Ying T, Prabakaran P, Du L, et al. Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. Nat Commun. 2015 Sep 15;6:8223. DOI:https://doi.org/10.1038/ncomms9223. PubMed PMID: 26370782; PubMed Central PMCID: PMCPMC 4571279.
   PubMed Web of Science ®Google Scholar
• Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021 Feb 10;592(7855):616–622. DOI:https://doi.org/10.1038/s41586-021-03324-6. PubMed PMID: 33567448.
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Zhou D, Supasa P, et al. Antibody evasion by the P.1 strain of SARS-CoV-2. Cell. 2021. DOI:https://doi.org/10.1016/j.cell.2021.03.055.
   Google Scholar
• Tegally H, Wilkinson E, Lessells RJ, et al. Sixteen novel lineages of SARS-CoV-2 in South Africa. Nat Med. 2021 Mar;27(3):440-446. DOI:https://doi.org/10.1038/s41591-021-01255-3. PubMed PMID: 33531709.
   PubMed Web of Science ®Google Scholar
• Supasa P, Zhou D, Dejnirattisai W, et al. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021 Feb 18;184(8):2201–2211.e7. DOI:https://doi.org/10.1016/j.cell.2021.02.033. PubMed PMID: 33743891; PubMed Central PMCID: PMCPMC7891044.
   PubMed Web of Science ®Google Scholar
• Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021 Mar 8;593(7857):130–135. DOI:https://doi.org/10.1038/s41586-021-03398-2. PubMed PMID: 33684923.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Arora P, Gross R, et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021 Mar 20;184(9):2384–2393.e12. DOI:https://doi.org/10.1016/j.cell.2021.03.036. PubMed PMID: 33794143; PubMed Central PMCID: PMCPMC7980144.
   PubMed Web of Science ®Google Scholar
• Li Q, Nie J, Wu J, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 Feb 23;184(9):2362–2371.e9. DOI:https://doi.org/10.1016/j.cell.2021.02.042. PubMed PMID: 33735608; PubMed Central PMCID: PMCPMC7901273.
   PubMed Web of Science ®Google Scholar